Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
批准号:
7986321
负责人:
Yong Lin
金额:
$45.61万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-09 至 2015-03-31
关键词:
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAnalysis of VarianceApoptosisBenzo(a)pyreneBronchoalveolar Lavage FluidButanonesCancer EtiologyCancer ModelCancer cell lineCarcinogensCell SurvivalCellsCessation of lifeChemosensitizationChronicCigaretteCo-ImmunoprecipitationsCoculture TechniquesConditioned Culture MediaDNA DamageDevelopmentDimethyl SulfoxideEpidermal Growth Factor ReceptorEpithelial CellsEpoxy CompoundsExtracellular Signal Regulated KinasesFigs - dietaryGene TargetingGeneticGlycolsHumanIn VitroInflammationInflammatoryKnockout MiceLeadLesionLinkLiteratureLungLung InflammationLung NeoplasmsMAP Kinase GeneMalignant NeoplasmsMalignant neoplasm of lungMediatingMembrane GlycoproteinsMethylnitrosoureaMitogen-Activated Protein KinasesModelingMolecularMolecular TargetMucin-1 Staining MethodMusNon-Small-Cell Lung CarcinomaNude MiceOrganOutcome StudyParticulateParticulate MatterPathogenesisPathway interactionsPrevention therapyPreventive InterventionProcessRNA InterferenceReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingResearchRiskRoleSignal TransductionSmokeSystemTNF geneTNFRSF1A geneTestingTherapeutic InterventionTobaccoTobacco-Associated CarcinogenTumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaUnited StatesXenograft procedureair filterairway inflammationcancer cellcarcinogenesiscell transformationcigarette smoke-inducedcigarette smokingcigarette smokingcytokinefetal bovine serumhuman TNFRSF1A proteinin vivoinsightlung cancer preventionlung carcinogenesislung developmentmacrophageneutralizing antibodynoveloverexpressionpreventpublic health relevancetumortumor necrosis factor alpha receptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer-related death in the United States. Cigarette smoke (CS) is a well- known risk for lung cancer. Inflammation has clearly emerged as a key process contributing to the development of lung and other cancers. However, the gene targets and pathways modulated by inflammation that impact cancer development have not been clearly elucidated. This application builds on emerging studies from the literature and by our group that implicate an important role for MUC1 in linking inflammation and carcinogenesis. The central hypothesis of this application is that airway inflammation resulting from CS induces MUC1 expression, which triggers lung cancer development through potentiation of the EGFR- mediated Akt and extracellular signal-regulated kinases (ERK) pathways. This hypothesis will be tested in the three Specific Aims: 1. To determine if the pro-inflammatory cytokine TNF? mediates CS-induced MUC1 expression in bronchial epithelial cells and if MUC1 potentiates cell transformation; 2. To determine if MUC1 facilitates CS-induced bronchial epithelial cell transformation through potentiation of the EGFR-mediated Akt and ERK pathways; 3. To investigate the role of MUC1 in CS-induced lung carcinogenesis with CS-derived carcinogen benzo(a)pyrene (BaP)- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced A/J lung cancer models and in a xenografted human lung tumor model in nude mice. Successful completion of this study will likely reveal a new molecular mechanism of CS-induced lung carcinogenesis that involves Muc1 and will provide new insights into how inflammation influences cell transformation and tumor development and could identify novel targets for prevention and intervention therapy for lung cancer.
PUBLIC HEALTH RELEVANCE: The proposed research will likely unravel a new molecular mechanism of tobacco smoke-induced lung carcinogenesis. The outcome from this study may lead to new strategies for lung cancer prevention and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting RIP3-mediated Necroptosis for Chemosensitization
-
批准号:9251788
-
项目类别:
-
资助金额:$23.71万
-
财政年份:2016
-
负责人:Yong Lin
-
依托单位:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
-
批准号:8434940
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2010
-
负责人:Yong Lin
-
依托单位:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
-
批准号:8240086
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2010
-
负责人:Yong Lin
-
依托单位:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
-
批准号:8641691
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2010
-
负责人:Yong Lin
-
依托单位:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
-
批准号:8125009
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2010
-
负责人:Yong Lin
-
依托单位:
Nutrient Flavonoids and Lung Cancer Prevention
-
批准号:7447899
-
项目类别:
-
资助金额:$10.25万
-
财政年份:2007
-
负责人:Yong Lin
-
依托单位:
Nutrient Flavonoids and Lung Cancer Prevention
-
批准号:7319665
-
项目类别:
-
资助金额:$10.25万
-
财政年份:2007
-
负责人:Yong Lin
-
依托单位:
海外基金